InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Fuhrman Alan, 董事. Director active across 4 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 16 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €140k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 13 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Fuhrman Alan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
1,376 股@ US$9.1295.4% 占其流量Common StockSEC:0001193125-26-111100:0
701 股@ US$9.1292.6% 占其流量Common StockSEC:0001193125-25-206439:0
24,727 股Common StockSEC:0001104659-25-065312:0
10,060 股0Common StockSEC:0001104659-25-049658:0
1,238 股@ US$9.7755.9% 占其流量Common StockSEC:0000950170-25-041550:0
9,500 股@ US$15.995273.8% 占其流量Common StockSEC:0000950170-24-120099:0
标准退出：2025年1月28日 (T+90)
954 股@ US$12.4785.6% 占其流量Common StockSEC:0000950170-24-107391:0
23,000 股0Common StockSEC:0001628280-24-025219:0
4,095 股0Common StockSEC:0001104659-24-062978:0
932 股@ US$12.4785.6% 占其流量Common StockSEC:0000950170-24-033848:0
1,463 股@ US$12.5035100.0% 占其流量Common StockSEC:0001209191-23-050090:0
5,150 股0Common StockSEC:0001628280-23-022461:0
4,648 股0Common StockSEC:0001104659-23-064645:0
4,818 股0Common StockSEC:0001104659-22-063507:0
12,376 股0Common StockSEC:0001628280-21-011361:0
1,106 股0Common StockSEC:0001104659-21-070519:0
16 条申报中的 16 条
About Fuhrman Alan
Fuhrman Alan is Administrateur and has filed 16 disclosures in total. Across the 16 most recent sampled disclosures, buy amounts total EUR 140430, sell amounts total EUR 0, and the most frequent transaction nature is Attribution, with disclosures ranging from 2021-05-21 to 2026-03-17. He is also Chief Financial Officer at Tyra Biosciences, Inc., and Director at SpringWorks Therapeutics, Inc. and Esperion Therapeutics, Inc.
